Stay updated on Response to Immunotherapy in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Response to Immunotherapy in Lung Cancer Clinical Trial page.

Latest updates to the Response to Immunotherapy in Lung Cancer Clinical Trial page
- Check4 days agoChange DetectedThe study record now shows updated investigator contacts and new participating sites, including Hartford HealthCare Cancer Institute at Manchester Medical Hospital and other listed collaborators, while several previous contacts and sites were removed.SummaryDifference1%

- Check11 days agoChange DetectedThere were no text changes recorded for this page. The study record content remains as previously captured.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page’s software/UI release identifier was updated from Revision v3.5.2 to Revision v3.5.3, reflecting a maintenance update without changes to the displayed study record content.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check32 days agoChange DetectedNo additions or deletions were observed on the page.SummaryDifference0.1%

- Check40 days agoChange DetectedAdded Familial multiple polyposis syndrome to the Conditions section of the study record.SummaryDifference0.1%

Stay in the know with updates to Response to Immunotherapy in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Response to Immunotherapy in Lung Cancer Clinical Trial page.